FutureWiseResearch: Global Market Research Reports, USA, UK

Overview

Radiofrequency Ablation Devices Market Overview:

According to FutureWise analysis, the market for Radiofrequency Ablation Devices in 2023 is US$ 4.82 billion, and is expected to reach US$ 12.04 billion by 2031 at a CAGR of 12.10%.

A medical treatment known as radiofrequency ablation (RFA) uses heat radiation to reduce the size of tumors and other growths in the body or to relieve discomfort. Numerous medical disorders, such as benign or malignant tumors, persistent neck or back pain, and chronic venous insufficiency felt in the legs, are treated using this method. The procedure necessitates the introduction of a needle-like probe into the patient's body and is quite similar to a needle biopsy. The radiofrequency waves are transmitted from the probe to the surrounding tissue in the targeted area after the device has been firmly and precisely placed. The cells in the area eventually die. Once the cells have died, the immune system begins to remove them from the body, which causes an internal reaction and causes the nodule size to decrease.

The procedure is patient-friendly because it is minimally invasive, does not require a lengthy recovery period, and can be carried out in a typical hospital setting or the patient's home. The patient can proceed with normal daily activities within 24-30 hours of the procedure's completion. Due to a rise in cancer patients and the associated increase in research and development and investments in cancer treatments, the market for radiofrequency ablation devices is expected to expand globally. Most commonly, cancers of the kidney, lungs, liver, adrenal gland, thyroid, and pancreas are treated using the RFA approach.

FutureWise Market Research has published a report that provides an insightful analysis of radiofrequency ablation devices market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry.

According to the analysis conducted by FutureWise research analysts, the radiofrequency ablation devices market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

Major players included in the Radiofrequency Ablation Devices Market are:

Medtronic
AngioDynamics
Covidien
Ethicon
Zenomed
Atricure, Inc
Baren-Boym
Huaian Aofu Surgical Instruments Co., Ltd
Medsphere
Stryker Corporation

Recent developments by key players in Radiofrequency Ablation Devices Market:

In April 2022- EnCompass Clamp was introduced by AtriCure as a component of its Isolator Synergy ablation system. The platform uses synergy radiofrequency and features parallel closure, consistent pressure, and bespoke power. It will be utilized to ablate cardiac tissue during cardiac surgery to improve the efficiency of concurrent surgical ablations.

One of the major variables affecting the overall market share is patients' preference for minimally invasive procedures over open surgery. Due to fewer hospital stays, quicker recuperation times, and lower pain levels than traditional surgeries, the acceptance and appeal of minimally invasive techniques have increased dramatically in recent years. In addition, more cardiac ablation surgeries are anticipated, and atrial fibrillation is more common in the general population. The atrial fibrillation minimally invasive ablation therapy has the highest efficacy, lowest risk, and best patient convenience. The growing benefits of less invasive treatment options employing ablation devices will propel the market for radiofrequency ablation devices throughout the forecast period. Moreover, tiny tumors can be successfully treated with radiofrequency ablation, which can be repeated if the cancer returns. Increased public awareness of effective ablation techniques also propels the market ahead. The extensive application of electrophysiology to eliminate defective tissues that cause aberrant heart rhythms or cardiac arrhythmia is another development in the industry. Novel product advancements, such as the creation of next-generation ablation devices with robotic navigation systems, are also driving the market. Manufacturers are also creating non-thermal, non-tumescent, and non-sclerosant endovenous ablation devices to treat superficial vein reflux. Due to factors like expanding consumer healthcare spending capacity and significant advancements in the medical sector, particularly in developing nations, the market is expected to grow. However, the global market for radiofrequency ablation devices is constrained by the availability of alternative therapies, low awareness of the process, and expensive therapeutic costs. The market for ablation devices is also anticipated to be hampered by an unfavorable regulatory environment and issues pertaining to device reuse and reprocessing in emerging nations.

Radiofrequency Ablation Devices Market Video Sample:

Radiofrequency Ablation Devices Market Segmentation:

By Type

RF Generators
Reusable Products
Disposable Products

By Application

Cardiovascular Disease Treatment
Cancer Treatment
Ophthalmologic Treatment
Urologic Treatment
Orthopedic Treatment
Others

By Region

North America
Latin America
Europe
Asia-Pacific
Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. The rising incidence of chronic diseases, rising demand for minimally invasive operations, rising product releases, and rising strategic initiatives by important industry players are the major variables propelling the growth of the North American radiofrequency (RF) ablation devices market. For instance, the American Cancer Society, Inc. projects that in 2022, there will be around 236,750 new instances of lung cancer diagnosed in the US. The same authority also predicted that in 2022, kidney cancer would be responsible for 79,000 new cases and 13,920 fatalities. Therefore, it is anticipated that the increasing burden of cancer will increase demand for ablation, thereby fueling market expansion.

Competitive Landscape:

Tier 1 players- established companies in the market with major market share
Tier 2 players
New Entrants
Emerging players which are growing rapidly

FutureWise Takeaways:

Growth prospects
SWOT analysis
Key trends
Key data points affecting market growth

Objectives of the Study:

To provide with an exhaustive analysis on the Radiofrequency Ablation Devices Market by type, by application and by region.
To cater comprehensive insights on factors such as drivers, restraints, trends, opportunity, and additionally segmental and regional factors impacting market growth.
To evaluate current market trends and forecast micro-markets and the overall market projections which are represented in the format of data-sets and ppt.
To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
To provide information on competitors which includes landscape mapping, technological advancements, R&D spending, news concerning strategic alliances, and new product launches.

Flexible Delivery Model:

We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
The customization Mobility Care offered are free of charge with purchase of any license of the report
You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

1. Market Introduction
- 1. Objectives of the Study
  2. Market Definition
  3. Market Scope
  3.1. Years Considered for the Study
  3.2. Market Covered
  4. Currency
  5. Limitations
  6. Stakeholders
2. Research Methodology
- 1. Research Data
  1.1. Secondary Data
  1.1.1. Key Data from Secondary Sources
  1.2. Primary Data
  1.2.1. Key Data from Primary Sources
  2. Market Size Estimation
  3. Market Breakdown and Data Triangulation
  4. Assumptions for the Study
3. Executive Summary
- 1. Market Outlook
  2. Segment Outlook
  3. Competitive Insights
4. Radiofrequency Ablation Devices Market Variables, Trends and Scope
- 1. Market Lineage Outlook
  2. Penetration and Growth Prospect Mapping
  3. Industry Value Chain Analysis
  4. Cost Analysis Breakdown
  5. Type Overview
  6. Regulatory Framework
  6.1. Reimbursement Framework
  6.2. Standards and Compliances
5. Market Overview
- 1. Market Dynamics
  1.1. Market Driver Analysis
  1.1.1. Increasing focus of Radiofrequency Ablation Devices Market Companies on Brand Protection
  1.1.2. Untapped Opportunities in Emerging Regions
  1.2. Market Restraint Analysis
  1.2.1. High Cost Associated with Implementation of Predictive Analysis
  1.3. Industry Challenges
  1.3.1. Presence of Ambiguous Regulatory Framework
6. Radiofrequency Ablation Devices Market Analysis Tools
- 1. Industry Analysis - Porter’s
  1.1. Supplier Power
  1.2. Buyer Power
  1.3. Substitution Threat
  1.4. Threat from New Entrants
  1.5. Competitive Rivalry
  2. Pestel Analysis
  2.1. Political Landscape
  2.2. Environmental Landscape
  2.3. Social Landscape
  2.4. Type Landscape
  2.5. Legal Landscape
  3. Major Deals And Strategic Alliances Analysis
  3.1. Joint Ventures
  3.2. Mergers and Acquisitions
  3.3. Licensing and Partnership
  3.4. Type Collaborations
  3.5. Strategic Divestments
  4. Market Entry Strategies
  5. Case Studies
7. Radiofrequency Ablation Devices Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)
- 1. RF Generators
  2. Reusable Products
  3. Disposable Products
8. Radiofrequency Ablation Devices Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
- 1. Cardiovascular Disease Treatment
  2. Cancer Treatment
  3. Ophthalmologic Treatment
  4. Urologic Treatment
  5. Orthopedic Treatment
  6. Others
9. North America Radiofrequency Ablation Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
- 1. Introduction
  2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
  2.1. U.S.A
  2.2. Canada
  2.3. Mexico
  3. Market Size (USD Million) Forecast for North America 2023-2031
10. Latin America Radiofrequency Ablation Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
- 1. Introduction
  2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
  2.1. Brazil
  2.2. Venezuela
  2.3. Argentina
  2.4. Rest of Latin America
  3. Market Size (USD Million) Forecast for Latin America 2023-2031
11. Europe Radiofrequency Ablation Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
- 1. Introduction
  2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
  2.1. Germany
  2.2. U.K
  2.3. France
  2.4. Italy
  2.5. Spain
  2.6. Russia
  2.7. Poland
  2.8. Rest of Europe
  3. Market Size (USD Million) Forecast for Europe 2023-2031
12. Asia Pacific Radiofrequency Ablation Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
- 1. Introduction
  2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
  2.1. Japan
  2.2. China
  2.3. India
  2.4. Australia and New Zealand
  2.5. ASEAN
  2.6. Rest of Asia Pacific
  3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031
13. Middle East and Africa Radiofrequency Ablation Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
- 1. Introduction
  2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
  2.1. GCC
  2.2. Israel
  2.3. South Africa
  2.4. Rest of MEA
  3. Market Size (USD Million) Forecast for MEA 2023-2031
14. Market Share Analysis and Competitive Landscape
- 1. Global Landscape - Key Players, Revenue and Presence
  2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
  3. Global Emerging Companies
  4. North America - Market Share Analysis and Key Regional Players
  5. Europe - Market Share Analysis and Key Regional Players
  6. Asia Pacific - Market Share Analysis and Key Regional Players
  7. Global Key Player - Growth Matrix
15. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
- 1. Medtronic
  1.1. Company Overview
  1.2. Product Portfolio
  1.3. SWOT Analysis
  1.4. Financial Overview
  1.5. Strategic Overview
  2. AngioDynamics
  2.1. Company Overview
  2.2. Product Portfolio
  2.3. SWOT Analysis
  2.4. Financial Overview
  2.5. Strategic Overview
  3. Covidien
  3.1. Company Overview
  3.2. Product Portfolio
  3.3. SWOT Analysis
  3.4. Financial Overview
  3.5. Strategic Overview
  4. Ethicon
  4.1. Company Overview
  4.2. Product Portfolio
  4.3. SWOT Analysis
  4.4. Financial Overview
  4.5. Strategic Overview
  5. Zenomed
  5.1. Company Overview
  5.2. Product Portfolio
  5.3. SWOT Analysis
  5.4. Financial Overview
  5.5. Strategic Overview
  6. Atricure, Inc
  6.1. Company Overview
  6.2. Product Portfolio
  6.3. SWOT Analysis
  6.4. Financial Overview
  6.5. Strategic Overview
  7. Baren-Boym
  7.1. Company Overview
  7.2. Product Portfolio
  7.3. SWOT Analysis
  7.4. Financial Overview
  7.5. Strategic Overview
  8. Huaian Aofu Surgical Instruments Co., Ltd
  8.1. Company Overview
  8.2. Product Portfolio
  8.3. SWOT Analysis
  8.4. Financial Overview
  8.5. Strategic Overview
  9. Medsphere
  9.1. Company Overview
  9.2. Product Portfolio
  9.3. SWOT Analysis
  9.4. Financial Overview
  9.5. Strategic Overview
  10. Stryker Corporation
  10.1. Company Overview
  10.2. Product Portfolio
  10.3. SWOT Analysis
  10.4. Financial Overview
  10.5. Strategic Overview
16. Pre and Post COVID-19 Impact
- 1. Positive influence on the healthcare industry
  2. The financial disruption of the manufacturing sector
  3. Impact of COVID-19 on emerging companies
  4. Significant mandates in the healthcare regulations initiated by administrations
  5. The overall economic slowdown of the developing and developed nations
17. FutureWise SME Key Takeaway Points for Client

Data Pack license: Data Pack license: $1250

Single user license: Single user license: $2850

Multi user license: Multi user license: $3850

Corporate license: Corporate license: $5000

Ask for Discount

Buy Now

Customize This Report

Partner

Report Overview

Table of Contents

List of Tables

List of figures

Overview

Table of Contents

Report Overview

Table of Contents

List of Tables

List of figures

Need Assistance

What you get

What's included

Our Clients